Pharmaceutical
Technology
Health

Cleveland BioLabs

$1.45
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.00 (-0.28%) Today
-$0.03 (-1.75%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell CBLI and other stocks, options, ETFs, and crypto commission-free!

About CBLI

Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. Read More It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY.

Employees
16
Headquarters
Buffalo, New York
Founded
2003
Market Cap
16.50M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
2.68K
High Today
$1.45
Low Today
$1.45
Open Price
$1.45
Volume
2.54K
52 Week High
$3.16
52 Week Low
$1.00

Collections

Pharmaceutical
Technology
Health
Biotechnology
Biopharmaceutical
Research And Development
US
North America

CBLI Earnings

-$0.11
-$0.09
-$0.06
-$0.04
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 13, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.